Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Cerilliant
Deloitte
Mallinckrodt
Federal Trade Commission
Argus Health
Citi
McKesson
Express Scripts

Generated: December 12, 2018

DrugPatentWatch Database Preview

GADOXETATE DISODIUM - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for gadoxetate disodium and what is the scope of gadoxetate disodium patent protection?

Gadoxetate disodium is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Gadoxetate disodium has thirty-three patent family members in twenty-four countries.

One supplier is listed for this compound.

Summary for GADOXETATE DISODIUM
International Patents:33
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Suppliers / Packagers: 1
Bulk Api Vendors: 5
Clinical Trials: 5
Formulation / Manufacturing:see details
DailyMed Link:GADOXETATE DISODIUM at DailyMed
Pharmacology for GADOXETATE DISODIUM
Synonyms for GADOXETATE DISODIUM
135326-22-6
D04288
D0X2FT
Eovist (TN)
GADOLINIUM(3+) ION DISODIUM 2-({2-[BIS(CARBOXYLATOMETHYL)AMINO]-3-(4-ETHOXYPHENYL)PROPYL}({2-[BIS(CARBOXYLATOMETHYL)AMINO]ETHYL})AMINO)ACETATE
Gadoxetate disodium (USAN)
Gadoxetate sodium (JAN)
LP072305

US Patents and Regulatory Information for GADOXETATE DISODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare EOVIST gadoxetate disodium SOLUTION;INTRAVENOUS 022090-001 Jul 3, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Hlthcare EOVIST gadoxetate disodium SOLUTION;INTRAVENOUS 022090-002 Feb 4, 2013 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Hlthcare EOVIST gadoxetate disodium SOLUTION;INTRAVENOUS 022090-001 Jul 3, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Bayer Hlthcare EOVIST gadoxetate disodium SOLUTION;INTRAVENOUS 022090-002 Feb 4, 2013 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for GADOXETATE DISODIUM

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB05/021 United Kingdom ➤ Sign Up PRODUCT NAME: GADOXETIC ACID, OPTIONALLY IN THE FORM OF A SALT; REGISTERED: SE 18929 20040326; SE 18930 20040326; UK PL 00053/0348 20041110; UK PL 00053/0349 20041110
0405704/01 Switzerland ➤ Sign Up FORMER OWNER: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, DE
0182 Netherlands ➤ Sign Up 300182, 20100627, EXPIRES: 20150626
/2005 Austria ➤ Sign Up PRODUCT NAME: GADOXETSAEURE DINATRIUM; NAT. REGISTRATION NO/DATE: 1-25757, 1-25758 20050302; FIRST REGISTRATION: SE 18929, 18930 20040326
00182 Netherlands ➤ Sign Up PRODUCT: GADOXETINEZUUR, DESGEWENST IN DE VORM VAN EEN ZOUT, IN HET BIJZONDER HET NATRIUMZOUT. FIRST AUTHORIZATION NO/DATE: 1829 AND 18930, 20040326 (SE); NATIONAL AUTHORIZATION NO/DATE: RVG 31393 AND 31394, 20050113
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Medtronic
Chinese Patent Office
Colorcon
Chubb
Boehringer Ingelheim
Cerilliant
Moodys
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.